Skip to main content
    A

    ASP Isotopes Inc. Common Stock (ASPI)

    Official site

    BASIC MATERIALS • CHEMICALS • NASDAQ

    $1.54
    -0.20 (-11.49%)

    Market Cap: $266.76M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    ASP Isotopes Inc. Common Stock (ASPI) Financials: Revenue, Profit and Cash Flow

    Updated Aug 14, 2026. Financial statements from company filings, amounts in US dollars.

    ASP Isotopes Inc. Common Stock reported revenue of $23.85M for the fiscal year ended Dec 31, 2025, up 475.5% from the year before. That year, net income was -$159.84M with a net margin of -670.2%, operating cash flow was -$37.78M and free cash flow was -$47.43M. The quarter ended Jun 30, 2026 had revenue of $5.12M and net income of -$33.99M.

    Revenue and Margins

    Over the 6 years to Dec 2025, revenue grew from $22.63M, a compound annual rate of 0.9%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$23.85M+475.5%14.3%-251.2%-670.2%
    Dec 2024$4.14M+857.0%38.6%-636.0%-782.4%
    Dec 2023$433.03KN/A32.1%-3704.6%-3762.9%
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021N/AN/AN/AN/AN/A
    Dec 2019$22.63MN/A47.6%-45.3%-45.3%
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Jun 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2019
    Revenue$23.85M$4.14M$433.03K$0N/A$22.63M
    Cost of revenue$20.44M$2.54M$294.06K$0$19.38K$11.86M
    Gross profit$3.40M$1.60M$138.97K$0-$19.38K$10.76M
    Research and development$15.07M$3.14M$764.58K$1.27M$41.61K$0
    Operating income-$59.91M-$26.35M-$16.04M-$5.10M-$2.61M-$10.26M
    Net income-$159.84M-$32.42M-$16.29M-$4.95M-$2.61M-$10.26M
    EBITDAN/AN/AN/A-$4.95M-$2.59M$3.84M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$5.12M$4.18M$16.66M$4.89M$1.20M$1.10M$1.19M$1.09M$1.02M$840.35K$433.03K$0
    Gross profit$1.48M$1.67M$2.08M$423.18K$572.00K$327.00K$605.13K$293.98K$421.02K$278.87K$138.97K$0
    Operating income-$34.20M-$24.89M-$25.02M-$14.97M-$11.97M-$7.95M-$7.65M-$5.43M-$7.46M-$5.81M-$4.02M-$3.95M
    Net income-$33.99M-$7.12M-$63.33M-$12.89M-$75.16M-$8.46M-$9.22M-$7.36M-$8.88M-$6.96M-$4.17M-$4.22M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $201.38M by $78.19M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2019
    Total assets$498.02M$94.35M$27.54M$12.50M$7.14MN/A
    Current assets$399.92M$65.74M$10.51M$3.30M$3.22MN/A
    Cash and equivalents$279.57M$61.89M$7.91M$2.39M$2.95MN/A
    Total liabilities$235.12M$43.18M$8.71M$2.68M$1.14MN/A
    Short-term debt$584.00K$939.00K$470.40K$33.85K$84.97KN/A
    Long-term debt$200.79M$33.43M$0N/AN/AN/A
    Shareholder equity$204.15M$47.90M$16.30M$9.82M$6.00MN/A
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$572.05M$587.67M$498.02M$225.89M$135.91M$90.87M$94.35M$84.13M$54.76M$45.39M$27.54M$11.87M
    Total liabilities$297.26M$288.65M$235.12M$129.29M$107.60M$45.15M$43.18M$42.11M$40.40M$32.36M$8.71M$3.23M
    Cash and equivalents$219.60M$207.35M$285.56M$113.94M$67.68M$55.97M$61.89M$51.57M$28.26M$23.89M$7.91M$2.29M
    Shareholder equity$264.69M$289.00M$204.15M$74.07M$25.23M$42.51M$47.90M$38.70M$11.01M$10.52M$16.30M$8.64M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
    Operating cash flow-$37.78M-$16.70M-$5.41M-$2.94M-$577.69K
    Capital expenditures$9.65M$11.37M$2.33M$4.47M$2.99M
    Free cash flow-$47.43M-$28.07M-$7.74M-$7.41M-$3.57M
    Dividends paid$0$2.78MN/AN/AN/A
    Share repurchases$17.96M$3.65M$563.47K$1.47MN/A
    Investing cash flow-$110.79M-$11.37M-$2.45M-$4.47M-$2.99M
    Financing cash flow$371.60M$82.53M$13.39M$6.64M$6.50M
    Fiscal years ended Dec 2021 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow-$23.33M-$17.76M-$17.85M-$8.86M-$7.90M-$3.17M-$3.76M-$4.84M-$5.12M-$2.97M-$2.06M-$653.28K
    Capital expenditures$4.09M$6.14M$2.40M$3.15M$1.75M$2.36M$3.02M$4.48M$2.62M$1.25M$1.14M$681.55K
    Free cash flow-$27.42M-$23.90M-$20.25M-$12.01M-$9.65M-$5.53M-$6.78M-$9.32M-$7.75M-$4.22M-$3.20M-$1.33M
    Last 12 quarters

    Frequently Asked Questions About ASPI

    What is ASP Isotopes Inc. Common Stock's annual revenue?

    ASP Isotopes Inc. Common Stock reported revenue of $23.85M for the fiscal year ended Dec 31, 2025.

    How fast is ASP Isotopes Inc. Common Stock's revenue growing?

    Revenue was up 475.5% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is ASP Isotopes Inc. Common Stock profitable?

    No. ASP Isotopes Inc. Common Stock reported net income of -$159.84M for the fiscal year ended Dec 31, 2025, with a net margin of -670.2%.

    How much free cash flow does ASPI generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$37.78M minus capital expenditures of $9.65M produced free cash flow of -$47.43M.

    How much debt does ASP Isotopes Inc. Common Stock have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $200.79M, short-term debt of $584.00K and cash and equivalents of $279.57M.